胺用于治疗创伤后应激障碍:现状
Rachel Fremont1, Oneysha Brown1, Adriana Feder1
1Depression and Anxiety Center for Discovery and Treatment, Department of Psychiatry (all authors), and Nash Family Department of Neuroscience (Murrough), Icahn School of Medicine at Mount Sinai, New York.
概括
胺在治疗创伤后应激障碍 (PTSD) 中表现有前途,可快速减轻症状. 然而,它的有效性因人群而异,需要进一步研究最佳的PTSD治疗策略.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 创伤后应激障碍 (PTSD) 是一种慢性精神健康状况,对许多人来说,治疗效果有限.
- 现有的PTSD治疗方法往往产生部分反应或没有反应,这表明需要新的治疗方法.
研究的目的:
- 审查胺作为潜在的PTSD治疗的新兴作用.
- 根据目前的证据,评估胺在减少PTSD症状方面的疗效.
主要方法:
- 审查关于胺在治疗PTSD中的使用现有文献.
- 分析涉及单次和重复静脉注射 (IV) 胺剂的研究.
主要成果:
- 单次静脉注射的氨酸剂量显示,PTSD症状迅速减少.
- 在平民样本中,重复输液胺改善了PTSD症状,但在军事人群中没有显著改善.
- 与米达佐拉姆药物的比较显示,在平民组有显著的改善.
结论:
- 胺是一种潜在的快速起作用的PTSD治疗.
- 需要进一步的研究来确定从胺治疗中受益最多的患者群体.
- 研究胺与心理治疗的结合可能为PTSD提供了增强的治疗效益.
相关概念视频
Post-traumatic Stress Disorder
76
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
76
Parenteral Anesthetics: Overview
159
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
159
Electroconvulsive Therapy
75
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
75


